<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1140</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2023-19-3-77-84</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Epidemiological aspects of the incidence and mortality of cervical cancer (literature review)</article-title><trans-title-group xml:lang="ru"><trans-title>Эпидемиологические аспекты заболеваемости раком шейки матки и смертности от него (обзор литературы)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7585-7998</contrib-id><name-alternatives><name xml:lang="en"><surname>Kulieva</surname><given-names>G. Z.</given-names></name><name xml:lang="ru"><surname>Кулиева</surname><given-names>Г. З.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Gunel Zakir kyzy Kulieva</p><p>10 Marshala Zhukova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>Гюнель Закир кызы Кулиева</p><p>249036 Обнинск, ул. Маршала Жукова, 10</p></bio><email>gunelka2010@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mkrtchyan</surname><given-names>L. S.</given-names></name><name xml:lang="ru"><surname>Мкртчян</surname><given-names>Л. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>10 Marshala Zhukova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Маршала Жукова, 10</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Krikunova</surname><given-names>L. I.</given-names></name><name xml:lang="ru"><surname>Крикунова</surname><given-names>Л. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>10 Marshala Zhukova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Маршала Жукова, 10</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanov</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Иванов</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>10 Marshala Zhukova St., Obninsk 249036; 6 Miklukho-Maklaya St., Moscow 117198</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Маршала Жукова, 10; 117198 Москва, ул. Миклухо-Маклая, 6</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8784-8415</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaprin</surname><given-names>A. D.</given-names></name><name xml:lang="ru"><surname>Каприн</surname><given-names>А. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>6 Miklukho-Maklaya St., Moscow 117198; 10 Marshala Zhukova St., Obninsk 249036; 2-oy Botkinskiy Proezd, Moscow 125284</p></bio><bio xml:lang="ru"><p>117198 Москва, ул. Миклухо-Маклая, 6; 249036 Обнинск, ул. Маршала Жукова, 10; 125284 Москва, 2-й Боткинский проезд, 3</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiology Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Медицинский радиологический научный центр им. А.Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Рeoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский университет дружбы народов»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Medical Research Radiology Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-10-27" publication-format="electronic"><day>27</day><month>10</month><year>2023</year></pub-date><volume>19</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>77</fpage><lpage>84</lpage><history><date date-type="received" iso-8601-date="2023-10-27"><day>27</day><month>10</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-10-27"><day>27</day><month>10</month><year>2023</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/1140">https://ojrs.abvpress.ru/ojrs/article/view/1140</self-uri><abstract xml:lang="en"><p>A review of domestic and foreign literature was carried out. Statistical analysis of the available literature showed that at present, despite the improvement of screening programs around the world, there is a steady increase in the incidence and mortality of cervical cancer in women of reproductive age with a high percentage of patients with advanced forms, whose proportion is 32 %. The percentage of deaths during the year since the verification of the disease in 2020 was 12.6 %.</p><p>In the structure of mortality in the Russian population, malignant diseases occupy the second ranking place, accounting for 13.6 % after diseases of the cardiovascular system – 43.9 %. Diseases of the female reproductive system account for 18.2 %. At the same time, cervical cancer in the overall structure of oncological morbidity occupies the 4th ranking place, and among the organs of the reproductive system – the 2nd place – 13.3 %, yielding to breast cancer (47.8 %). These figures reflect the lack of implemented programs aimed at reducing the incidence of cervical cancer.</p></abstract><trans-abstract xml:lang="ru"><p>Проведен обзор доступной отечественной и зарубежной литературы. ее анализ показал, что в настоящее время, несмотря на совершенствование скрининговых программ во всем мире, отмечается стабильный рост показателей заболеваемости раком шейки матки и смертности от него у женщин репродуктивного возраста, с высокой долей больных с запущенными формами, составляющей 32 %. частота летальных исходов в течение года с момента верификации заболевания в 2020 г. составила 12,6 %.</p><p>В структуре смертности населения России злокачественные новообразования занимают 2-е ранговое место, составляя 13,6 % после болезней сердечно-сосудистой системы (43,9 %). среди онкопатологии заболевания женской репродуктивной системы составляют 18,2 %. При этом рак шейки матки в общей структуре онкологической заболеваемости занимает 4-е ранговое место, а среди органов репродуктивной системы – 2-е место (13,3 %), уступая раку молочной железы (47,8 %). данные показатели отражают малую эффективность медицинских и социальных программ, реализация которых направлена на снижение заболеваемости раком шейки матки, а также на повышение выживаемости и качества жизни пациенток с данной патологией.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>screening</kwd><kwd>mortality</kwd><kwd>incidence</kwd><kwd>human papillomavirus</kwd><kwd>World Health Organization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>скрининг</kwd><kwd>смертность</kwd><kwd>заболеваемость</kwd><kwd>вирус папилломы человека</kwd><kwd>Всемирная организация здравоохранения</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The work was performed without external funding</funding-statement><funding-statement xml:lang="ru">Работа проведена без спонсорской поддержки</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Zhang S., Xu H., Zhang L., Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 2020;32(6):720–28. DOI: 10.21147/j.issn.1000-9604.2020.06.05</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Choi S., Ismail A., Pappas-Gogos G., Boussios S. HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens 2023;12:298. DOI: 10.3390/pathogens12020298</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Nygård M., Nygård S. The future of cervical cancer prevention: from “one-size-fits-all” to personalized screening. J Pers Med 2023;13:161. DOI: 10.3390/jpm13020161</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gopu P., Antony F., Cyriac S. et al. Updates on systemic therapy for cervical cancer. Ind J Med Res 2021;154(2):293–302. DOI: 10.4103/ijmr.IJMR_4454_20</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6): 394–424. DOI: 10.3322/caac.21492</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209–49. DOI: 10.3322/caac.21660</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Arbyn M., Weiderpass E., Bruni L. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8(2):191–203. DOI: 10.1016/s2214-109X(19)30482-6</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Fowler J.R., Maani E.V., Dunton C.J., Jack B.W. Cervical Cancer. 2022. Treasure Island: StatPearls Publishing, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK431093/.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Singh D., Vignat J., Lorenzoni V. et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2023;11(2):197–206. DOI: 10.1016/S2214-109X(22)00501-0</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ferlay J., Ervik M., Lam F. et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. Available at: https://gco.iarc.fr/today.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34. DOI: 10.3322/caac.21551</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shrestha A.D., Neupane D., Vedsted P., Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev 2018;19(2):319–24. DOI: 10.22034/APJCP.2018.19.2.319</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lemp J.M., De Neve J.W., Bussmann H. et al. Lifetime prevalence of cervical cancer screening in 55 lowand middle-income countries. JAMA 2020;324(15):1532–42. DOI: 10.1001/jama.2020.16244</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Singh G.K., Azuine R.E., Siahpush M. Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. Int J Mch Aids 2012;1(1):17–30. DOI: 10.21106/ijma.12</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Broberg G., Wang J., Östberg A.L. et al. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study. PLoS One 2018;13(1):e0190171. DOI: 10.1371/journal.pone.0190171</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Endale H., Mulugeta T., Habte T. The socioeconomic impact of cervical cancer on patients in ethiopia: evidence from Tikur Anbessa Specialized Hospital. Cancer Manag Res 2022;14:1615– 25. DOI: 10.2147/CMAR.S352389</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Akinyemiju T., Ogunsina K., Sakhuja S. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO’s Study on Global Ageing and Adult Health (SAGE). BMJ Open 2016;6:012753. DOI: 10.1136/bmjopen-2016-012753</mixed-citation></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Xu T., Yang X., He X. The study on cervical cancer burden in 127 countries and its socioeconomic influence factors. J Epidemiol Glob Health 2023;13:154–61. DOI: 10.1007/s44197-022-00081-1</mixed-citation><mixed-citation xml:lang="ru">Xu T., Yang X., He X. The study on cervical cancer burden in 127 countries and its socioeconomic influence factors. J Epidemiol Glob Health 2023;13:154–61. DOI: 10.1007/s44197-022-00081-1</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><mixed-citation>Hull R., Mbele M., Makhafola T. et al. Cervical cancer in low and middleincome countries (review). Oncol Lett 2020;20:2058–74.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bhatla N., Berek J.S., CuelloFredes M. et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019;145(1):129–35. DOI: 10.1002/ijgo.12749</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Koh W.J., Abu-Rustum N.R., Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(1):64–84. DOI: 10.6004/jnccn.2019.0001</mixed-citation></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2019 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2020. 250 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2019 г. (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, 2020. 250 с.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2020 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. M.: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2021. 252 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2020 г. (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, 2021. 252 с.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">The state of oncological care for the population of Russia in 2021, Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Состояние онкологической помощи населению России в 2021 г. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России, 2022. 239 с.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Krikunova L.I. Radiation therapy for cervical cancer. Prakticheskaya onkologiya = Practical Oncology 2002;3(3):194–9. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Крикунова Л.И. Лучевая терапия рака шейки матки. Практическая онкология 2002;3(3):194–9.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Bohman Ya.V. Guide to oncogynecology. Leningrad: Meditsina, 1989. Pp. 164–172. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Бохман Я.В. Руководство по онкогинекологии. Л.: Медицина, 1989. C. 164–72.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Polyakova V.A. Oncogynecology. Guide for doctors. Moscow: Meditsinskaya kniga, 2001. 152 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Полякова В.А. Онкогинекология. Руководство для врачей. M.: Медицинская книга, 2001. 152 с.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Leonov M.G., Shelyakina T.V., Lukyanova L.V., Chernov S.N. Historical aspects of cytological screening for cervical cancer. Volgogradskiy nauchno-medicinskiy zhurnal = Volgograd Medical Scientific Journal 2012;36(4):6–11. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Леонов М.Г., Шелякина Т.В., Лукьянова Л.В., Чернов С.Н. Исторические аспекты цитологического скрининга рака шейки матки. Волгоградский научно-медицинский журнал 2012;36(4):6–11.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Mkrtchyan L.S., Kaprin A.D., Ivanov S.A. et al. Efficiency of treatment of locally advanced cervical cancer depending on prognostic factors. Voprosy onkologii = Oncology Issues 2019;65(4):584–9. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Мкртчян Л.С., Каприн А.Д., Иванов С.А. И др. Эффективность лечения местнораспространенного рака шейки матки в зависимости от факторов прогноза. Вопросы онкологии 2019;65(4):584–9.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Mkrtchyan L.S. Chemoradiation treatment of locally advanced cervical cancer and prognostic factors. Thesis … doctor of medical sciences. Obninsk, 2019. 328 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Мкртчян Л.С. Химиолучевое лечение местнораспространенного рака шейки матки и факторы прогноза. Автореф. Диc. … д-ра мед. Наук. Обнинск, 2019. 328 с.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical guidelines for the drug treatment of cervical cancer. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2018;8(3s2):178–89. Available at: https://www.rosoncoweb.ru/standards/RUSSCO/2018/2018-12.pdf. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Хохлова С.В., Коломиец Л.А., Кравец О.А. И др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные опухоли: практические рекомендации RUSSCO 2018;8(3s2):178–89. Доступно по: https://www.rosoncoweb.ru/standarts/RUSSCO/2018/2018-12.pdf.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical recommendations for the drug treatment of cancer of the cervix. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2020;10(3s2):221–41. Available at: https://rosoncoweb.ru/standards/RUSSCO/2020/2020-13.pdf. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Хохлова С.В., Коломиец Л.А., Кравец О.А. И др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные опухоли: практические рекомендации RUSSCO 2020;10(3s2):221–41. Доступно по: https://rosoncoweb.ru/standarts/RUSSCO/2020/2020-13.pdf.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Cervical Cancer. Clinical recommendations of the Association of Oncologists of Russia. Moscow: Ministry of Health of Russia, 2019. 66 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Рак шейки матки. Клинические рекомендации Ассоциации онкологов России. М.: Минздрав России, 2019. 66 c.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Каприн А.Д., Мардынский Ю.С. Терапевтическая радиология. Национальное руководство. М.: ГЭОТАР-Медиа, 2018. 704 с. Kaprin A.D., Mardynskiy Yu.S. Therapeutic radiology. National leadership. Moscow: GEOTAR-Media, 2018. 704 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Каприн А.Д., Мардынский Ю.С. Терапевтическая радиология. Национальное руководство. М.: ГЭОТАР-Медиа, 2018. 704 с.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Khokhlova S.V., Dengina N.V., Kolomiets L.A. et al. Practical recommendations for the drug treatment of cancer of the cervix. Zlokachestvennye opukholi: prakticheskie rekomendatsii RUSSCO = Malignant tumors: practice guidelines RUSSCO 2017;7(3s2):158–67. Available at: https://www.rosoncoweb.ru/ standards/RUSSCO/2017/recoms2017_11.pdf. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Хохлова С.В., Деньгина Н.В., Коломиец Л.А. И др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные опухоли: практические рекомендации RUSSCO 2017;7(3s2):158–67. Доступно по: https://www.rosoncoweb.ru/standarts/RUSSCO/2017/recoms2017_11.pdf.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><mixed-citation>World Health Organization (WHO). WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. Geneva: World Health Organization, 2018. Available at: https://www.who.int/news/item/18-05-2018-who-dgcalls-for-all-countries-to-take-action-to-help-end-the-sufferingcaused-by-cervical-cancer.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>World Health Organization (WHO). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization, 2020.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization, 2021.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Brisson M., Kim J.J., Canfell K. et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lowermiddle-income countries. Lancet 2020;395(10224):575–90. DOI: 10.1016/S0140-6736(20)30068-4</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Canfell K., Kim J.J., Brisson M. et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lowermiddle-income countries. Lancet 2020;395(10224):591–603. DOI: 10.1016/S0140-6736(20)30157-4.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Bruni L., Saura-Lázaro A., Montoliu A. et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med 2021;144(106399):1–11. DOI: 10.1016/j.ypmed.2020.106399</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Briolat J., Dalstein V., Saunier M. et al. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007;121(10):2198–204. DOI: 10.1002/ijc.22959</mixed-citation></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Shipulina O.Yu. Epidemiological features and measures for the prevention of oncogynecological pathology of papillomavirus etiology. Thesis … candidate of medical sciences. Moscow, 2013. 24 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Шипулина О.Ю. Эпидемиологические особенности и меры профилактики онкогинекологической патологии папилломавирусной этиологии. Автореф. Дис. … канд. Мед. Наук. М., 2013. 24 с.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Protasova A.E. Cervical intraepithelial neoplasia and cervical cancer. Is human papillomavirus the only risk factor? Effektivnaya farmakoterapiya = Effective pharmacotherapy 2019;15(32):42–6. (In Russ.). DOI: 10.33978/2307-3586-2019-15-32-42-46</mixed-citation><mixed-citation xml:lang="ru">Протасова А.Э. Цервикальная интраэпителиальная неоплазия и рак шейки матки. Вирус папилломы человека – единственный фактор риска? Эффективная фармакотерапия 2019;15(32):42–6. DOI: 10.33978/2307-3586-2019-15-32-42-46</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><mixed-citation>ARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. Lyon, 2007. 636 p.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12–9. DOI: 10.1002/(SICI)10969896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Bruni L., Albero G., Serrano B. et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World, 2021. 314 p.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Ashamalla H., Ashamalla M., McFarlane S.I. COVID-19 pandemic and the new state of oncology practice: an editorial. Am J Med Case Rep 2020;8(9):311, 312. DOI: 10.12691/ajmcr-8-9-13</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Maringe C., Spicer J., Morris M. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020;21(8):1023–34. DOI: 10.1016/S1470-2045(20)30388-0</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Chino J., Annunziata C.M., Beriwal S. et al. The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes. Gynecol Oncol 2020;159(3):607–10. DOI: 10.1016/j.ygyno.2020.09.015</mixed-citation></ref></ref-list></back></article>
